A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
Titel:
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
Auteur:
Pérez-Rodríguez, Sonia de la Caridad Rodríguez-González, Meiby Ochoa-Azze, Rolando Climent-Ruiz, Yanet Alberto González-Delgado, Carlos Paredes-Moreno, Beatriz Valenzuela-Silva, Carmen Rodríguez-Noda, Laura Perez-Nicado, Rocmira González-Mugica, Raúl Martínez-Pérez, Marisel Sánchez-Ramírez, Belinda Hernández-García, Tays Díaz-Machado, Alina Tamayo-Rodríguez, Maura Martín-Trujillo, Alis Rubino-Moreno, Jorman Suárez-Batista, Anamary Dubed-Echevarría, Marta Teresa Pérez-Guevara, María Amoroto-Roig, Mayté Chappi-Estévez, Yanet Bergado-Báez, Gretchen Pi-Estopiñán, Franciscary Chen, Guang-Wu Valdés-Balbín, Yury García-Rivera, Dagmar Verez-Bencomo, Vicente